Is Alzheimer's a Disorder of Ageing and Why Don't Mice get it? The Centrality of Insulin Signalling to Alzheimer's Disease Pathology

Research output: Chapter in Book/Report/Conference proceedingConference paper

Abstract

The amyloid cascade hypothesis has had considerable importance in driving forward the molecular understanding of Alzheimer's disease (AD) pathology. One component of that cascade might be glycogen synthase kinase-3 (GSK3), a kinase that appears to be activated by A beta and in turn phosphorylates tau. GSK3 is also inhibited by insulin signalling and insulin resistance, and diabetes is a major risk factor for AD. We hypothesise, as others have done, that insulin signalling is central to the pathological process, with evidence that both genetic and environmental risk factors for AD involve the insulin pathway. We also postulate that transgenic mice provide only a partial model for AD, as insulin signalling acts as a protective factor against A beta toxicity; also, the well-established relationship between insulin signalling and longevity might explain why the single most important risk factor for AD is age.
Original languageEnglish
Title of host publicationUnknown
Place of PublicationBERLIN
PublisherSpringer
Pages129 - 152
Number of pages24
ISBN (Print)978-3-642-04299-7
DOIs
Publication statusPublished - 2010
Event24th Symposium on Medicine and Research of Alzhemers Disease - Paris, France
Duration: 6 Apr 2009 → …

Publication series

NameDIABETES, INSULIN AND ALZHEIMER'S DISEASE

Conference

Conference24th Symposium on Medicine and Research of Alzhemers Disease
Country/TerritoryFrance
CityParis
Period6/04/2009 → …

Fingerprint

Dive into the research topics of 'Is Alzheimer's a Disorder of Ageing and Why Don't Mice get it? The Centrality of Insulin Signalling to Alzheimer's Disease Pathology'. Together they form a unique fingerprint.

Cite this